Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for Yeztugo® (lenacapavir) 300-mg tablet as a ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5432, a study assessing factors that may affect how long-acting antiretroviral ...

A groundbreaking HIV prevention injection will only achieve its full impact if scientific advances are matched by clear, ...

Gilead stock is closely tied to its HIV treatments. But with Biktarvy's patent expirations looming, can the giant survive?

Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent." In this state, they are largely invisible and unassailable. As long as ...

– Latest Data from the PURPOSE Program Further Demonstrates the Safety and Efficacy Profile of Twice-Yearly Lenacapavir for HIV Prevention – “Striving for continuous progress in HIV means delivering ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

Charlie Sheen reveals his HIV-positive status and launches "Chasing The Cure" initiative with Dr. Oz.

A man has been declared HIV-free, in a case that “upends our understanding of what’s required” for a cure, according to The New Scientist. He was the seventh patient found to be clear of the virus ...